National has committed $25 million to bringing a new cancer treatment into New Zealand’s publicly funded health system. The pledge is intended to make an option described as revolutionary available to eligible patients through public services. The article examines what the promise means for access, implementation and the timing of patient care. It also compares National’s position with the policies of other parties. Their public positions indicate whether the proposal has support beyond National and whether voters are being given a clear choice. The pledge matters because access to a new treatment depends on sustained funding and enough clinical capacity to treat patients. The piece lays out the competing party stances so voters can judge the proposal on more than its headline figure.